|
[1]
|
Cohen, J.I. (2000) Epstein-Barr Virus Infection. New England Journal of Medicine, 343, 481-492. https://doi.org/10.1056/nejm200008173430707
|
|
[2]
|
Kimura, H. and Cohen, J.I. (2017) Chronic Active Epstein-Barr Virus Disease. Frontiers in Immunology, 8, Article ID: 1867. https://doi.org/10.3389/fimmu.2017.01867
|
|
[3]
|
中华医学会血液学分会淋巴细胞学组, 中华医学会儿科学分会血液学组, 中华医学会感染病学分会. 慢性活动性EB病毒病诊治专家共识(2025版) [J]. 中华医学杂志, 2025, 105(17): 1322-1330.
|
|
[4]
|
Okano, M., Kawa, K., Kimura, H., Yachie, A., Wakiguchi, H., Maeda, A., et al. (2005) Proposed Guidelines for Diagnosing Chronic Active Epstein‐Barr Virus Infection. American Journal of Hematology, 80, 64-69. https://doi.org/10.1002/ajh.20398
|
|
[5]
|
Kawada, J., Ito, Y., Ohshima, K., Yamada, M., Kataoka, S., Muramatsu, H., et al. (2023) Updated Guidelines for Chronic Active Epstein-Barr Virus Disease. International Journal of Hematology, 118, 568-576. https://doi.org/10.1007/s12185-023-03660-5
|
|
[6]
|
Xu, W., Jiang, X., Chen, J., Mao, Q., Zhao, X., Sun, X., et al. (2020) Chronic Active Epstein-Barr Virus Infection Involving Gastrointestinal Tract Mimicking Inflammatory Bowel Disease. BMC Gastroenterology, 20, Article No. 257. https://doi.org/10.1186/s12876-020-01395-9
|
|
[7]
|
Wei, A., Li, Z., Ma, H., Zhang, L., Zhang, J., He, L., et al. (2022) Clinical Analysis of Chronic Active Epstein-Barr Virus Infection Involving the Gastrointestinal Tract. Pediatric Infectious Disease Journal, 42, 13-19. https://doi.org/10.1097/inf.0000000000003734
|
|
[8]
|
Xing, Y., Yang, J., Lian, G., Chen, S., Chen, L. and Li, F. (2017) Chronic Active Epstein-Barr Virus Infection Associated with Hemophagocytic Syndrome and Extra-Nodal Natural Killer/T-Cell Lymphoma in an 18-Year-Old Girl. Medicine, 96, e6845. https://doi.org/10.1097/md.0000000000006845
|
|
[9]
|
Suzuki, T., Sato, Y., Okuno, Y., Torii, Y., Fukuda, Y., Haruta, K., et al. (2024) Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology, 44, Article No. 103. https://doi.org/10.1007/s10875-024-01701-0
|
|
[10]
|
He, X., Wang, J., Song, D. and Wang, Z. (2022) Development of a Nomogram to Predict the Risk of Chronic Active Epstein-Barr Virus Infection Progressing to Hemophagocytic Lymphohistiocytosis. Frontiers in Medicine, 9, Article ID: 826080. https://doi.org/10.3389/fmed.2022.826080
|
|
[11]
|
Henter, J., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. (2007) HLH‐2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131. https://doi.org/10.1002/pbc.21039
|
|
[12]
|
Quintanilla-Martinez, L., Swerdlow, S.H., Tousseyn, T., Barrionuevo, C., Nakamura, S. and Jaffe, E.S. (2023) New Concepts in EBV-Associated B, T, and NK Cell Lymphoproliferative Disorders. Virchows Archiv, 482, 227-244. https://doi.org/10.1007/s00428-022-03414-4
|
|
[13]
|
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M.A. and Bosch, X. (2014) Adult Haemophagocytic Syndrome. The Lancet, 383, 1503-1516. https://doi.org/10.1016/s0140-6736(13)61048-x
|
|
[14]
|
Canna, S.W. and Marsh, R.A. (2020) Pediatric Hemophagocytic Lymphohistiocytosis. Blood, 135, 1332-1343. https://doi.org/10.1182/blood.2019000936
|
|
[15]
|
La Rosée, P., Horne, A., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., et al. (2019) Recommendations for the Management of Hemophagocytic Lymphohistiocytosis in Adults. Blood, 133, 2465-2477. https://doi.org/10.1182/blood.2018894618
|
|
[16]
|
Henter, J.I., Tondini, C. and Pritchard, J. (2004) Histiocyte disorders. Critical Reviews in Oncology/Hematology, 50, 157-174. https://doi.org/10.1016/j.critrevonc.2004.01.002
|
|
[17]
|
Bergsten, E., Horne, A., Aricó, M., Astigarraga, I., Egeler, R.M., Filipovich, A.H., et al. (2017) Confirmed Efficacy of Etoposide and Dexamethasone in HLH Treatment: Long-Term Results of the Cooperative HLH-2004 Study. Blood, 130, 2728-2738. https://doi.org/10.1182/blood-2017-06-788349
|
|
[18]
|
Lehmberg, K., McClain, K.L., Janka, G.E. and Allen, C.E. (2014) Determination of an Appropriate Cut‐Off Value for Ferritin in the Diagnosis of Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 61, 2101-2103. https://doi.org/10.1002/pbc.25058
|
|
[19]
|
Cetica, V., Sieni, E., Pende, D., Danesino, C., De Fusco, C., Locatelli, F., et al. (2016) Genetic Predisposition to Hemophagocytic Lymphohistiocytosis: Report on 500 Patients from the Italian Registry. Journal of Allergy and Clinical Immunology, 137, 188-196.e4. https://doi.org/10.1016/j.jaci.2015.06.048
|
|
[20]
|
Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissell, D., Meller, J., et al. (2011) Hypomorphic Mutations in PRF1, MUNC13-4, and STXBP2 Are Associated with Adult-Onset Familial HLH. Blood, 118, 5794-5798. https://doi.org/10.1182/blood-2011-07-370148
|
|
[21]
|
Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., et al. (2014) Development and Validation of the Hscore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome. Arthritis & Rheumatology, 66, 2613-2620. https://doi.org/10.1002/art.38690
|
|
[22]
|
Kimura, H. and Fujiwara, S. (2019) Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases. Frontiers in Pediatrics, 6, Article ID: 417. https://doi.org/10.3389/fped.2018.00417
|
|
[23]
|
Kimura, H., Hoshino, Y., Kanegane, H., Tsuge, I., Okamura, T., Kawa, K., et al. (2001) Clinical and Virologic Characteristics of Chronic Active Epstein-Barr Virus Infection. Blood, 98, 280-286. https://doi.org/10.1182/blood.v98.2.280
|
|
[24]
|
Sawada, A., Inoue, M. and Kawa, K. (2017) How We Treat Chronic Active Epstein-Barr Virus Infection. International Journal of Hematology, 105, 406-418. https://doi.org/10.1007/s12185-017-2192-6
|
|
[25]
|
Bollard, C.M. and Cohen, J.I. (2018) How I Treat T-Cell Chronic Active Epstein-Barr Virus Disease. Blood, 131, 2899-2905. https://doi.org/10.1182/blood-2018-03-785931
|